Intercure Ltd. INCR

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $0.97
Market Cap $53.04M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-2.1% YoY
$270.20M
3-Yr CAGR: -11.4%
Net Income ↓-614.5% YoY
-$35.71M
Net Margin: -13.2%
Free Cash Flow ↓-39.0% YoY
-$29.41M
FCF Yield: -55.45%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
-5.3%
ROA: -5.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (INCR)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016
FY 2019 $-5.9M $-0.0M $-28.2M
FY 2020 $65.0M $32.0M $-1.2M +79.8% $0.1M $-20.7M +26.4%
FY 2021 $219.7M +237.8% $91.1M $2.6M +318.6% $5.1M $-8.9M +57.0%
FY 2022 $388.7M +76.9% $155.1M $-1.1M -141.1% $-17.3M $-37.0M -315.5%
FY 2023 $355.6M -8.5% $105.1M $-1.6M -47.1% $-20.9M $-28.3M +23.6%
FY 2024 $276.1M -22.3% $30.2M $-5.0M -217.5% $-15.2M $-21.2M +25.2%
FY 2025 $270.2M -2.1% $33.2M $-35.7M -614.5% $-19.0M $-29.4M -39.0%
$

Valuation

Market Price $0.97
Market Cap $53.04M
Enterprise Value $178.59M
P/E Ratio N/A
P/B Ratio 0.08
FCF Yield -55.45%
Dividend Yield N/A
Shares Outstanding 54,681,300
%

Profitability & Margins

Gross Margin 12.28%
Operating Margin -1.56%
Net Margin -13.22%
Return on Equity (ROE) -5.29%
Return on Assets (ROA) -5.17%
Asset Turnover 0.39x
Revenue 3-Yr CAGR -11.41%
🛡️

Financial Health & Liquidity

Current Ratio 106.79
Cash Ratio 15.67
Debt / Equity 0.255
Debt / Assets 0.249
Cash & Equivalents $46.47M
Total Debt $172.01M
Book Value / Share $12.36
💧

Cash Flow Efficiency

Operating Cash Flow -$19.03M
Capital Expenditures (CapEx) $10.38M
Free Cash Flow -$29.41M
OCF / Revenue -7.04%
FCF / Revenue -10.89%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share $12.36
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $690.55M
Total Liabilities $294.19M
Stockholders' Equity $675.60M
Current Assets $316.75M
Current Liabilities $2.97M